FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease (FRENCH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01220843
Recruitment Status : Completed
First Posted : October 14, 2010
Last Update Posted : April 28, 2016
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Centre Hospitalier Universitaire, Amiens

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2013
  Actual Study Completion Date : April 2013
JP Cristol, AS Bargnoux, AM Dupuy, M Morena, A Avignon and B Canaud. Biological markers of vascular calcifications in uremia. Médecine Nucléaire 2009; 33, 53-61.